Abstract
An anti-cancer drug sensitivity test was performed using a transplantable human osteosarcoma originated in the mandible (HOSIVIN-1). The drugs tested in this study were Adriamycin (ADM), Cis-platinum (CDDP), and Methotrexate (MTX)(high and low-dose). The effect of the drugs were judged according to the Battelle Columbus Laboratories Protocol (BCLP), and the following results were obtained.1) Growth inhibition was seen with all drugs.2) With respect to the duration of effect and the maximum rate of tumor inhibition, the most effective drug was losv-dose MTX followed by CDDP, high-dose MTX and ADM in that order.3) In the substantial weight change, only low-dose MTX group showed no weight loss. Refering to its low incidence of side effect as well, it was suggested that low-dose MIX was most useful in this experiment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Japanese Journal of Oral & Maxillofacial Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
